NCT00825942
Unknown
Phase 2
An Open-Label Study of the Effect of C-KAD Ophthalmic Solution on Asteroid Hyalosis
Overview
- Phase
- Phase 2
- Intervention
- C-KAD Ophthalmic Solution
- Conditions
- Asteroid Hyalosis
- Sponsor
- Chakshu Research, Inc.
- Enrollment
- 20
- Locations
- 1
- Primary Endpoint
- Reduction in the number of asteroid bodies
- Last Updated
- 17 years ago
Overview
Brief Summary
To determine the safety and initial efficacy of C-KAD ophthalmic solution in patients with asteroid hyalosis
Investigators
Eligibility Criteria
Inclusion Criteria
- •Presence of asteroid hyalosis
Exclusion Criteria
- •Active ocular infection
- •Ocular hypertension
- •Ocular inflammatory disorders
Arms & Interventions
C-KAD Ophthalmic Solution
Intervention: C-KAD Ophthalmic Solution
Outcomes
Primary Outcomes
Reduction in the number of asteroid bodies
Time Frame: 180
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
An Open-Label Study of an Ophthalmic Solution to Reduce Intraocular Pressure in Patients With Ocular HypertensionOcular HypertensionNCT00825396Chakshu Research, Inc.12
Unknown
Phase 2
Safety and Efficacy Study of an Ophthalmic Solution in Patients With Age-Related CataractCataractNCT00793091Chakshu Research, Inc.80
Unknown
Phase 2
Dose-Ranging Study of an Ophthalamic Solution in Patients With Loss of Visual Function Due to Age-Related Nuclear CataractNuclear CataractNCT00825721Chakshu Research, Inc.81
Completed
Phase 2
Assess the Safety and Efficacy of CsA Ophthalmic Gel in Subjects With Dry EyeDry EyeNCT03676335Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.240
Completed
Phase 3
Assess the Safety and Efficacy of CsA Ophthalmic Gel in Subjects With Moderate to Severe Dry Eye DiseaseDry EyeNCT04541888Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.644